Enliven Therapeutics, Inc. - Common Stock (NQ:ELVN)

45.59 +2.66 (+6.20%)

Streaming Delayed Price Updated: 4:00 PM EDT, Apr 9, 2026 Add to My Watchlist

Price and Volume

Volume	2,270,262
Open	42.93
Bid (Size)	45.01 (200)
Ask (Size)	46.20 (1,000)
Prev. Close	42.93
Today's Range	42.88 - 46.23
52wk Range	13.30 - 46.23
Shares Outstanding	41,151,111
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Enliven Theraeutics' (ELVN) Chief Medical Officer Sold 40,000 Shares for $1.2 Million ↗

March 28, 2026

This Boulder-based biotech, developing targeted cancer therapies, reported a notable insider sale as Phase 1 trials advance for key drug candidates.

Via The Motley Fool

Enliven Therapeutics Chief Scientific Officer Sells ELVN 20K Shares Worth Over $500k ↗

February 01, 2026

The Chief Scientific Officer of this biopharmaceutical company sold 20,000 shares in mid-January 2026, amid the company's stock rising 71% throughout the month.

Via The Motley Fool

Performance

YTD	+193.4%	+193.4%
1 Month	+50.8%	+50.8%
3 Month	+96.1%	+96.1%
6 Month	+114.1%	+114.1%
1 Year	+176.0%	+176.0%

More News

The $225B Precision Sprint: How Big Pharma is Beating the $170B Patent Cliff

January 12, 2026

From Equity Insider

Via GlobeNewswire

S&P 500, Nasdaq Futures Waver Ahead Of Supreme Court Ruling On Trump Tariffs: Why OPEN, ACON, FLYX, OSCR Are Trending After-Hours ↗

January 08, 2026

Via Stocktwits

Here are the top movers in Thursday's session. ↗

January 08, 2026

Via Chartmill

ELVN Stock Shot Up 60% Today – What’s Driving The Rally? ↗

January 08, 2026

Via Stocktwits

These stocks are gapping in today's session ↗

January 08, 2026

Via Chartmill

Resemble AI Unleashes Chatterbox Turbo: A New Era for Open-Source Real-Time Voice AI

December 15, 2025

Via TokenRing AI

With a 150% Rally and Big 2026 Catalysts Ahead, Is Amylyx Stock Getting a Second Chance? ↗

December 03, 2025

Via The Motley Fool

Scholar Rock Stock Is Still Down 40% From 2021 Highs — And One Investor Just Walked Away ↗

December 03, 2025

Via The Motley Fool

Terns Stock Surges 300% in One Year — What a New $43 Million Position Signals for Investors ↗

December 03, 2025

Via The Motley Fool

Relay Therapeutics Stock Has Jumped 60% in a Year — And One Investor Just Bought Nearly 4 Million More Shares ↗

December 03, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Monday's Intraday Session ↗

November 03, 2025

Via Benzinga

What's going on in today's pre-market session ↗

August 15, 2025

Via Chartmill

Enliven Posts Loss Beat and Cash Surge ↗

August 13, 2025

Via The Motley Fool

Meta To Rally Around 3%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

July 02, 2025

Via Benzinga

Enliven Short Interest Falls To 14-Month Low After Leukemia Trial Data, Goldman Initiates With ‘Buy’ ↗

June 23, 2025

Via Stocktwits

12 Health Care Stocks Moving In Friday's Intraday Session ↗

June 13, 2025

Via Benzinga

Greenbrier, RPM International, CVRx And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

April 08, 2025

Via Benzinga

This Alumis Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday ↗

October 31, 2024

Via Benzinga

Active Biotech Alert: FDA Approves 16 New Cancer Treatments as Global Cancer Rates Skyrocket

October 04, 2024

Via FinancialNewsMedia

Enliven Therapeutics' Leukemia Candidate Could Challenge Pfizer, AstraZeneca In Broader Target Market: Analyst ↗

September 09, 2024

Via Benzinga

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q2 2024 ↗

August 13, 2024

Via InvestorPlace

ELVN Stock Earnings: Enliven Therapeutics Beats EPS for Q1 2024 ↗

May 14, 2024

Via InvestorPlace

Enliven Therapeutics Shares First Look At Safety, Clinical Activity Of Lead Program ↗

April 11, 2024

Via Benzinga

Frequently Asked Questions

Is Enliven Therapeutics, Inc. - Common Stock publicly traded?

Yes, Enliven Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Enliven Therapeutics, Inc. - Common Stock trade on?

Enliven Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Enliven Therapeutics, Inc. - Common Stock?

The ticker symbol for Enliven Therapeutics, Inc. - Common Stock is ELVN on the Nasdaq Stock Market

What is the current price of Enliven Therapeutics, Inc. - Common Stock?

The current price of Enliven Therapeutics, Inc. - Common Stock is 45.59

When was Enliven Therapeutics, Inc. - Common Stock last traded?

The last trade of Enliven Therapeutics, Inc. - Common Stock was at 04/09/26 04:00 PM ET

What is the market capitalization of Enliven Therapeutics, Inc. - Common Stock?

The market capitalization of Enliven Therapeutics, Inc. - Common Stock is 1.88B

How many shares of Enliven Therapeutics, Inc. - Common Stock are outstanding?

Enliven Therapeutics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.